A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug ...

Almost 15 percent of U.S. adults aged 50 to 80 years are taking aspirin for primary cardiovascular disease prevention, ...

The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

Drug repurposing is undervalued, but it offers potential benefits for patients and healthcare systems, argue Ruth Langley and colleagues Drug repurposing involves finding new indications for ...

With all the painkillers out there, we sometimes forget one that has been around forever: aspirin! It has been called the ...

Addressing a longstanding controversy in cancer prevention, a large randomized trial showed that low-dose aspirin reduced the risk of colorectal cancer (CRC) in patients with Lynch syndrome just as ...

Medically reviewed by Jeffrey S. Lander, MD There are many types and combinations of drugs used to treat a myocardial infarction (MI), also known as a heart attack. These drugs can help prevent blood ...

Low-dose aspirin use was significantly associated with an increased risk for anemia among older Danish adults in a real-world setting, according to a study published in European Heart Journal ...

Low-dose aspirin may treat flu-induced blood vessel inflammation during pregnancy, thereby improving blood flow to the placenta. The corresponding study was published in Frontiers in Immunology. "This ...

In an analysis of more than 3,100 older adults, low-dose aspirin administered for 3 years did not affect the incidence or progression of age-related macular degeneration, according to study ...

Use of daily low-dose aspirin for 3 years didn't prevent age-related macular degeneration (AMD) in older adults, according to a secondary analysis of the randomized ASPREE trial.